Continuation of Dabigatran Therapy in “Real-World” Practice in Hong Kong

BACKGROUND: Dabigatran, an oral direct thrombin inhibitor, possesses several advantages over warfarin that can in principle simplify the management of stroke prevention in atrial fibrillation (AF). Nonetheless it remains unclear whether these advantages can translate to clinical practice and encoura...

Descripción completa

Detalles Bibliográficos
Autores principales: Ho, Mei Han, Ho, Chi Wai, Cheung, Emmanuel, Chan, Pak Hei, Hai, Jo Jo, Chan, Koon Ho, Chan, Esther W., Leung, Gilberto Ka Kit, Tse, Hung Fat, Siu, Chung Wah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4118845/
https://www.ncbi.nlm.nih.gov/pubmed/25084117
http://dx.doi.org/10.1371/journal.pone.0101245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4118845/
https://www.ncbi.nlm.nih.gov/pubmed/25084117
http://dx.doi.org/10.1371/journal.pone.0101245

Ejemplares similares